Legislative Affairs Director Bill Eley has been busy creating summaries of federal legislation important to community pharmacy. These one-page descriptions of proposed legislation in Congress quickly and easily explain what is in each of the bills, and why they are important.

This week's generics update from McKesson has information on launches of generic Nexium and Mirapex, service level updates, and more!

Due to system maintenance at Prime Therapeutics, our claims processing system will be unavailable for claims adjudication during the time frame listed below:

Saturday February 21, 2015 11:00 p.m. to Sunday February 22, 2015 3:00 a.m. (Central Time)    

During this downtime, claims will not be processed. 

If you have any questions regarding processing claims, please call the Prime Contact Center at 800.821.4795.

This week's Generic News includes information on launches of generic Mirapex and Nexium, as well as the latest on the Weekly Generics Campaign.

Late February 2015, generic Nexium® (Esomeprazole) will become available to the market. Esomeprazole will remain Non-Formulary for Medicare Part D Covered Persons and reject at point of sale (POS). The innovator product Nexium® will continue to be covered without prior approval* from the plan.